OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
John P. Evans, Panke Qu, Cong Zeng, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2340-2342
Open Access | Times Cited: 32
John P. Evans, Panke Qu, Cong Zeng, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2340-2342
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28
Evaluation of IgG binding capability to SARS-CoV-2 variants in early COVID-19 convalescent sera using an indirect ELISA
Behzad Hussain, Peizhe Zhao, Yu Liu, et al.
Virus Research (2025) Vol. 352, pp. 199520-199520
Open Access
Behzad Hussain, Peizhe Zhao, Yu Liu, et al.
Virus Research (2025) Vol. 352, pp. 199520-199520
Open Access
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
John P. Evans, Shan‐Lu Liu
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1459-1467
Open Access | Times Cited: 13
John P. Evans, Shan‐Lu Liu
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1459-1467
Open Access | Times Cited: 13
Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Xiaoman Li, Yongbing Pan, Qiangling Yin, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Xiaoman Li, Yongbing Pan, Qiangling Yin, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Delta-Omicron recombinant escapes therapeutic antibody neutralization
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106075-106075
Open Access | Times Cited: 11
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106075-106075
Open Access | Times Cited: 11
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 764-764
Open Access | Times Cited: 9
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 764-764
Open Access | Times Cited: 9
Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacron Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021–Oct 2022)
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1933-1933
Open Access | Times Cited: 9
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1933-1933
Open Access | Times Cited: 9
Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination
Li‐Jun Duan, Wen G. Jiang, Zhuang-Ye Wang, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104886-104886
Open Access | Times Cited: 10
Li‐Jun Duan, Wen G. Jiang, Zhuang-Ye Wang, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104886-104886
Open Access | Times Cited: 10
A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents
Yufen Zheng, Juan Pan, Minya Jin, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110151-110151
Open Access | Times Cited: 5
Yufen Zheng, Juan Pan, Minya Jin, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110151-110151
Open Access | Times Cited: 5
Forecast for peak infections in the second wave of the Omicron after the adjustment of zero-COVID policy in the mainland of China
Sheng-Tao Wang, Yong-Ping Wu, Li Li, et al.
Infectious Disease Modelling (2023) Vol. 8, Iss. 2, pp. 562-573
Open Access | Times Cited: 5
Sheng-Tao Wang, Yong-Ping Wu, Li Li, et al.
Infectious Disease Modelling (2023) Vol. 8, Iss. 2, pp. 562-573
Open Access | Times Cited: 5
Neutralization and Binding Capability of SARS-CoV-2 Variants by/of IgG Antibodies of Early COVID-19 Convalescent Inactivated Sera based on Indirect ELISA
Behzad Hussain, Peizhe Zhao, Bo Yang, et al.
(2024)
Open Access | Times Cited: 1
Behzad Hussain, Peizhe Zhao, Bo Yang, et al.
(2024)
Open Access | Times Cited: 1
Emergence of recombinant SARS-CoV-2 variants in California, 2020-2022
Rahil Ryder, Emily Smith, Deva Borthwick, et al.
(2024)
Open Access | Times Cited: 1
Rahil Ryder, Emily Smith, Deva Borthwick, et al.
(2024)
Open Access | Times Cited: 1
The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB
Bardia Karim, Mohammad Barary, Zahra Fereydouni, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 8
Open Access | Times Cited: 1
Bardia Karim, Mohammad Barary, Zahra Fereydouni, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 8
Open Access | Times Cited: 1
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14057-14057
Open Access | Times Cited: 8
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14057-14057
Open Access | Times Cited: 8
Literature review on COVID-19 vaccine efficacy in the immunocompromised population, and possible implications to future vaccination in kidney transplant patients
Joo Kyung Park, Sunil Bhandari
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Joo Kyung Park, Sunil Bhandari
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
Guinevere G. Connelly, Orville O. Kirkland, Seven Bohannon, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 8, pp. 100273-100273
Open Access | Times Cited: 7
Guinevere G. Connelly, Orville O. Kirkland, Seven Bohannon, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 8, pp. 100273-100273
Open Access | Times Cited: 7
Delta-Omicron recombinant escapes therapeutic antibody neutralization
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Quantitative evaluation of the role of Fangcang shelter hospitals in the control of Omicron transmission: A case study of the outbreak in Shanghai, China in 2022
Sheng-Tao Wang, Li Li, Juan Zhang, et al.
One Health (2022) Vol. 16, pp. 100475-100475
Open Access | Times Cited: 6
Sheng-Tao Wang, Li Li, Juan Zhang, et al.
One Health (2022) Vol. 16, pp. 100475-100475
Open Access | Times Cited: 6
Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Current Progress in Genomic and Genetic Research on Human Viral Diseases
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
Emergence of Recombinant SARS-CoV-2 Variants in California from 2020 to 2022
Rahil Ryder, Emily Smith, Deva Borthwick, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1209-1209
Open Access
Rahil Ryder, Emily Smith, Deva Borthwick, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1209-1209
Open Access
